Online citations, reference lists, and bibliographies.
← Back to Search

Migraine In Patients With Stroke And Antiphospholipid Antibodies

M. Silvestrini, Letizia Maria Cupini, M. Matteis, Roberto Simone, G. Bernardi
Published 1993 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
SYNOPSIS
This paper references
10.1111/j.1365-2141.1985.tb02989.x
Anticardiolipin antibodies in autoimmune thrombocytopenic purpura
E. N. Harris (1985)
10.1007/BF02802323
Antiphospholipid antibodies
M. Khamashta (1994)
Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.
E. N. Harris (1987)
Antiphospholipid antibodies in migraine patients
R Hering (1991)
associated with antiphospholipid antibodies
DC Hess (1992)
patients with antiphospholipid antibodies
J Montalban (1992)
10.3109/00313027509081688
STUDIES ON PHOSPHOLIPIDS IN THE ACTION OF A LUPUS COAGULATION INHIBITOR
T. Exner (1975)
Therapeutic Considerations for Stroke Patients With Antiphospholipid Antibodies
V. Babikian (1992)
10.1001/ARCHNEUR.1990.00530040114027
Migraine-related stroke in the context of the International Headache Society classification of head pain.
K. Welch (1990)
Risk of Recurrent Thromboembolic Events in Patients With Focal Cerebral Ischemia and Antiphospholipid Antibodies
S. Levine (1992)
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.
(1988)
10.1161/01.STR.22.6.750
Antiphospholipid antibodies in cerebral ischemia.
J. Montalbán (1991)
Cerebrovascular disease an antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease and the primary antiphospholipid syndrome
RA Asherson (1989)
10.1097/00005792-198911000-00003
Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients
D. Alarcón-Segovia (1989)
Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
(1988)
10.1097/00005792-198911000-00004
The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features
R. Asherson (1989)
Migraine and the lupus anticoagulant
SR Levine (1987)
10.1136/ard.46.8.605
Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.
R. Asherson (1987)
10.1002/ANA.410250303
Neurological disease associated with antiphospholipid antibodies
D. P. Briley (1989)
10.1111/j.1365-2141.1985.tb02988.x
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody
E. N. Harris (1985)
Stroke Associated With Antiphospholipid Antibodies
D. Hess (1992)
10.1017/S0317167100028183
Lupus anticoagulant, antiphospholipid antibodies and migraine.
M. Hogan (1988)
Therapeutic consideration for
VL Babikian (1985)
10.1111/j.1526-4610.1989.hed2901042.x
Migraine and Anti‐Phospholipid Antibodies
A. Shuaib (1989)



This paper is referenced by
10.1007/978-3-662-06657-7_13
Kopfschmerz bei Gefäßstörungen
H. Goebel (1997)
10.1001/ARCHINTE.163.9.1058
Headache and the risk of stroke: a prospective observational cohort study among 35,056 Finnish men and women.
P. Jousilahti (2003)
10.1080/10446670410001670436
Testing for Antiphospholipid Antibody (aPL) Specificities in Retrospective “Normal” Cerebral Spinal Fluid (CSF)
D. Sokol (2004)
10.1159/000069411
Migraine History and Migraine-Induced Stroke in the Dijon Stroke Registry
D. Sochůrková (1999)
10.1097/00043426-200210000-00018
Antiphospholipid Antibodies and Down Syndrome: A Case Series
Yolanda Requena-Silla (2002)
10.3389/fneur.2018.01001
Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy
T. Fleetwood (2018)
10.1001/ARCHNEUR.1997.00550160012009
Association between migraine and stroke in a large-scale epidemiological study of the United States.
K. Merikangas (1997)
10.1191/0961203303lu500oa
CNS dysfunction in the antiphospholipid syndrome
A. Katzav (2003)
10.1155/1996/654071
Pathophysiology of Headaches with a Prominent Vascular Component
J. Pareja (1996)
Testing for Antiphospholipid Antibody ( aPL ) Specificities in Retrospective “ Normal ” Cerebral Spinal Fluid ( CSF )
D. K. SOKOLa (2014)
10.3760/CMA.J.ISSN.1007-9742.2017.02.117
Antiphospholipid syndrome
Jallow Tracy (2017)
10.1191/096120398678919868
Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies
É. Hachulla (1998)
10.1111/j.1749-6632.2002.tb04242.x
Neurological and Neuroendocrine‐Cytokine Inter‐relationship in the Antiphospholipid Syndrome
J. Chapman (2002)
10.1007/978-3-7091-6770-0_4
Migräne und Schlaganfall
K. Zebenholzer (2000)
10.1191/0961203303lu392oa
Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies
J. Chapman (2003)
Emicrania nel LES: ruolo del fenomeno di Raynaud e degli anticorpi antifospolipidi Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon
V. Annese (2006)
10.4081/REUMATISMO.2006.50
[Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon].
V. Annese (2006)
10.1016/0248-8663(96)80676-X
Manifestations neurologiques associées aux anticorps antiphospholipides. Ou que restetil du neurolupus
É. Hachulla (1995)
10.1054/MEHY.1998.0745
The altered homeostatic theory: a holistic approach to multiple diseases, including atherosclerosis, ischemic diseases, and hypertension.
H. Hellstrom (1999)
10.1007/S11883-004-0065-Y
Headache and the risk of stroke
P. Jousilahti (2004)
10.1016/B978-0-7506-7418-8.00008-2
Chapter 8 – Cerebral Infarction and Migraine
Rima M. Dafer (2009)
10.1093/BRAIN/AWF007
Endothelin-1 potently induces Leão's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura?
J. Dreier (2002)
10.1007/s12026-016-8831-9
Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?
M. Noureldine (2017)
10.1016/j.rdc.2017.06.004
Central Nervous System Manifestations of Antiphospholipid Syndrome.
J. Graf (2017)
Semantic Scholar Logo Some data provided by SemanticScholar